ATE480625T1 - Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion - Google Patents
Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektionInfo
- Publication number
- ATE480625T1 ATE480625T1 AT07101045T AT07101045T ATE480625T1 AT E480625 T1 ATE480625 T1 AT E480625T1 AT 07101045 T AT07101045 T AT 07101045T AT 07101045 T AT07101045 T AT 07101045T AT E480625 T1 ATE480625 T1 AT E480625T1
- Authority
- AT
- Austria
- Prior art keywords
- chlamydia pneumoniae
- polypeptides
- infection
- prevention
- relates
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 241001647372 Chlamydia pneumoniae Species 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 239000012528 membrane Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 108090000994 Catalytic RNA Proteins 0.000 abstract 1
- 102000053642 Catalytic RNA Human genes 0.000 abstract 1
- 206010061041 Chlamydial infection Diseases 0.000 abstract 1
- 208000035086 Chlamydophila Infections Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000006065 biodegradation reaction Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 108091092562 ribozyme Proteins 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714673 | 1997-11-21 | ||
US10707898P | 1998-11-04 | 1998-11-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE480625T1 true ATE480625T1 (de) | 2010-09-15 |
Family
ID=9513667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07101045T ATE480625T1 (de) | 1997-11-21 | 1998-11-20 | Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion |
Country Status (6)
Country | Link |
---|---|
US (4) | US6559294B1 (de) |
AT (1) | ATE480625T1 (de) |
CY (1) | CY1106408T1 (de) |
DE (1) | DE69841894D1 (de) |
ES (1) | ES2352082T3 (de) |
PT (1) | PT1032674E (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141244B1 (en) * | 1992-03-02 | 2006-11-28 | Chiron Srl | Helicobacter pylori proteins useful for vaccines and diagnostics |
GB2303855B (en) * | 1994-07-01 | 1998-10-28 | Rican Limited | Helicobacter pylori antigenic protein preparation and immunoassays |
ES2283012T3 (es) * | 1996-01-04 | 2007-10-16 | Novartis Vaccines And Diagnostics, Inc. | Bacterioferritina de helicobacter pylori. |
US6908770B1 (en) * | 1998-07-16 | 2005-06-21 | Board Of Regents, The University Of Texas System | Fluid based analysis of multiple analytes by a sensor array |
JP2002531093A (ja) | 1998-12-01 | 2002-09-24 | アベンティス、パストゥール、リミテッド | クラミジア抗原および対応するdna断片ならびにその使用 |
DE69930147T2 (de) * | 1998-12-04 | 2007-01-11 | University Of Manitoba, Winnipeg | Zwei-schritte-verfahren zur impfung gegen chlamydia |
US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
US20080213264A1 (en) * | 1998-12-08 | 2008-09-04 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US7297341B1 (en) * | 1998-12-23 | 2007-11-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
EP1140999A1 (de) * | 1998-12-23 | 2001-10-10 | Aventis Pasteur Limited | Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen |
US6808713B1 (en) * | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
EP1163342B1 (de) * | 1999-03-12 | 2008-12-10 | Aventis Pasteur Limited | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon |
WO2000066739A2 (en) * | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
NZ517952A (en) * | 1999-09-20 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
JP4516258B2 (ja) * | 1999-09-21 | 2010-08-04 | 日本たばこ産業株式会社 | 新規タンパク質、それをコードする遺伝子及びそれらの利用法 |
AU1375501A (en) * | 1999-11-12 | 2001-05-30 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
NZ520200A (en) * | 1999-12-22 | 2004-04-30 | Aventis Pasteur | Polynucleotides encoding the Clamydia pneumoniae polypeptides omp P6 precursor gene product |
US20020082402A1 (en) * | 2000-04-04 | 2002-06-27 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US20020071831A1 (en) * | 2000-04-04 | 2002-06-13 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US6919187B2 (en) * | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US20040254130A1 (en) * | 2000-05-08 | 2004-12-16 | Murdin Andrew D | Chlamydia antigens and corresponding dna fragments and uses thereof |
MXPA02011587A (es) * | 2000-05-23 | 2004-07-30 | Nexell Therapeutics Inc | Reactivos para la seleccion de celulas y metodos de uso. |
ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
US7811592B2 (en) * | 2000-08-16 | 2010-10-12 | Auburn University | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia |
JP4534092B2 (ja) * | 2000-09-08 | 2010-09-01 | 第一三共株式会社 | 心不全治療剤 |
US7731980B2 (en) * | 2000-10-02 | 2010-06-08 | Emergent Product Development Gaithersburg Inc. | Chlamydia PMP proteins, gene sequences and uses thereof |
US7537772B1 (en) | 2000-10-02 | 2009-05-26 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, gene sequence and the uses thereof |
ATE420892T1 (de) * | 2000-12-14 | 2009-01-15 | Pasteur Institut | Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg |
US20070149474A1 (en) * | 2000-12-15 | 2007-06-28 | Auburn University | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia |
US8206724B2 (en) * | 2000-12-15 | 2012-06-26 | Auburn University | Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia |
US20030059896A1 (en) * | 2000-12-21 | 2003-03-27 | Shire Biochem Inc. | Novel chlamydia antigens and corresponding DNA fragments |
IL158293A0 (en) * | 2001-04-10 | 2004-05-12 | Agensys Inc | Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same |
CA2458854A1 (en) * | 2001-08-31 | 2003-03-06 | Chiron Srl | Helicobacter pylori vaccination |
US20080112965A1 (en) * | 2001-10-01 | 2008-05-15 | Aventis Pasteur Limited | Chlamydia OMP antigen |
WO2003067399A2 (en) * | 2002-02-07 | 2003-08-14 | Byington Carrie L | Method for creating and using a treatment protocol |
AU2003228711C1 (en) * | 2002-04-26 | 2010-01-07 | Board Of Regents, The University Of Texas System | Method and system for the detection of cardiac risk factors |
US20040192591A1 (en) * | 2002-11-22 | 2004-09-30 | Wooters Joseph L. | Composition for treating Chlamydia infections and method for identifying same |
US20070003568A1 (en) * | 2003-02-24 | 2007-01-04 | Alice Dautry-Varsat | Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
WO2004113374A2 (en) * | 2003-06-17 | 2004-12-29 | Intercell Ag | Chlamydia pneumoniae antigens |
US20050042214A1 (en) * | 2003-07-15 | 2005-02-24 | Gershwin M. Eric | Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
US8101431B2 (en) | 2004-02-27 | 2012-01-24 | Board Of Regents, The University Of Texas System | Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems |
CN105777867A (zh) * | 2004-05-11 | 2016-07-20 | 艾比吉诺米克斯合作公司 | 诱导t细胞死亡的表位 |
WO2006086019A2 (en) * | 2004-10-21 | 2006-08-17 | Optiscan Biomedical Corporation | Methods of treating diabetes |
EP1861414B9 (de) * | 2005-02-07 | 2011-04-06 | Gen-Probe Incorporated | Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b |
US8377398B2 (en) | 2005-05-31 | 2013-02-19 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to determination and use of white blood cell counts |
AU2006254891B2 (en) * | 2005-06-06 | 2011-04-14 | Gen-Probe Incorporated | Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample |
EP1905825A1 (de) * | 2006-09-29 | 2008-04-02 | greenovation Biotech GmbH | Galactosyltransferase |
WO2008136867A2 (en) * | 2006-12-04 | 2008-11-13 | Auburn University | Chlamydia pneumoniae vaccine and methods for administering such a vaccine |
US20090092969A1 (en) * | 2007-10-09 | 2009-04-09 | Michael Aye | Detection of atypical pneumonia |
WO2011041788A2 (en) * | 2009-10-02 | 2011-04-07 | The Trustees Of Columbia University In The City Of New York | Turkey viral hepatitis virus and uses thereof |
JP5565781B2 (ja) * | 2010-03-31 | 2014-08-06 | 有限会社山口ティー・エル・オー | 核酸クロマトグラフ法を利用した肺炎原因菌の検出方法 |
KR101311886B1 (ko) | 2010-05-26 | 2013-09-26 | 한국기초과학지원연구원 | 폐렴연쇄상구균의 분비단백질을 포함하는 폐렴 진단용 조성물 |
CN104725507B (zh) * | 2010-10-19 | 2018-12-21 | 梅奥医学教育和研究基金会 | 用于治疗神经疾病的人抗体及其诊断和治疗用途 |
ES2865068T3 (es) | 2011-01-14 | 2021-10-14 | Univ California | Anticuerpos terapéuticos contra la proteína ROR-1 y métodos para usarlos |
WO2014151011A1 (en) * | 2013-03-15 | 2014-09-25 | Georgetown University | Selective inhibitor of angiotensin ii |
WO2015106345A1 (en) * | 2014-01-16 | 2015-07-23 | Mcmaster University | Type iii secretion injectisome proteins for treatment and prevention of chlamydial infections |
CN114137209B (zh) * | 2021-02-01 | 2024-03-01 | 中国水产科学研究院黄海水产研究所 | 一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2321346T3 (es) | 1994-09-20 | 2009-06-04 | Hitachi Chemical Co., Ltd. | Polinucleotidos que codifican un polipeptido antigenico de chlamydia pneumoniae. |
US6493591B1 (en) * | 2000-07-19 | 2002-12-10 | Medtronic, Inc. | Implantable active fixation lead with guidewire tip |
-
1998
- 1998-11-20 ES ES07101045T patent/ES2352082T3/es not_active Expired - Lifetime
- 1998-11-20 AT AT07101045T patent/ATE480625T1/de not_active IP Right Cessation
- 1998-11-20 PT PT98954662T patent/PT1032674E/pt unknown
- 1998-11-20 DE DE69841894T patent/DE69841894D1/de not_active Expired - Lifetime
- 1998-11-23 US US09/198,452 patent/US6559294B1/en not_active Expired - Fee Related
-
2002
- 2002-11-07 US US10/289,762 patent/US7101963B2/en not_active Expired - Fee Related
-
2006
- 2006-03-02 US US11/366,942 patent/US7601531B2/en not_active Expired - Fee Related
-
2007
- 2007-03-15 CY CY20071100360T patent/CY1106408T1/el unknown
-
2009
- 2009-06-25 US US12/491,449 patent/US20090274701A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6559294B1 (en) | 2003-05-06 |
CY1106408T1 (el) | 2011-10-12 |
US7101963B2 (en) | 2006-09-05 |
ES2352082T3 (es) | 2011-02-15 |
US20090274701A1 (en) | 2009-11-05 |
US7601531B2 (en) | 2009-10-13 |
US20040006218A1 (en) | 2004-01-08 |
DE69841894D1 (de) | 2010-10-21 |
PT1032674E (pt) | 2007-03-30 |
US20070053927A1 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE480625T1 (de) | Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion | |
DK1032674T3 (da) | Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion | |
WO1999028475A3 (en) | Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection | |
Sedgley et al. | Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp. | |
DE3588239T3 (de) | Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren | |
WO2003008615A3 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene | |
WO2003008602A3 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene | |
RU2673733C2 (ru) | Способ амплификации днк на основе внедрения в цепь | |
Reingold et al. | Identification of a new Escherichia coli She haemolysin homolog in avian E. coli | |
DE69534747D1 (de) | Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure | |
US6391631B1 (en) | Bacterial plasmids | |
AU5162790A (en) | Probes, kits and methods for the detection and differentiation of mycobacteria | |
WO2002024904A2 (de) | Verfahren zur herstellung von ribonukleinsäure (rns) | |
AU2002342763A1 (en) | Process for the preparation of non-aromatic l-amino acids using strains of the enterobacteriaceae family | |
Ikehara | Possible Application of Entirely New Gene/Protein to Clinical Research | |
JP2008092948A (ja) | 検体中の標的核酸を検出するためのキットおよび方法 | |
ATE321862T1 (de) | Coryneforme bakterien transformiert mit dem pknd- gen kodierenden nukleotidsequenzen und deren verwendung zur herstellung von l -aminosäuren | |
Frossard | Listeria monocytogenes virulence factor expression and the production of oligonucleotide primers for a polymerase chain reaction to identify virulent strains. | |
EP1246943A2 (de) | Oligonukleotide zur amplifikation und zum nachweis von bakteriellen genen für extrazelluläre alkalische metallopeptidasen (apr), neutrale metallopeptidasen (npr) und serinpeptidasen (spr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |